id author title date pages extension mime words sentences flesch summary cache txt cord-313628-6610z7xk Igbinosa, Irogue Use of Remdesivir for Pregnant Patients with Severe Novel 2019 Coronavirus Disease 2020-08-07 .txt text/plain 707 49 54 title: Use of Remdesivir for Pregnant Patients with Severe Novel 2019 Coronavirus Disease Data from a randomized controlled trial during the Ebola epidemic suggests safety of remdesivir in pregnancy 4 ; however, pregnant women have largely been excluded from clinical trials for COVID -19 treatment options 5 . Here we briefly describe the treatment of three pregnant patients hospitalized at our institution with confirmed SARS-CoV-2 infection who met criteria for compassionate use protocol of remdesivir. As the COVID-19 pandemic continues and pregnant women remain at risk for adverse medical and obstetric outcomes, having safe and effective therapies, such as remdesivir, is crucial for this population 6 . Case A underscores that the potential side effect of hepatitis with remdesivir use, which has been reported 6-8% in the non-pregnant population, 2,3 may overlap with pregnancy-related causes of transaminitis, including IHCP. Compassionate Use of Remdesivir for Patients with Severe Covid-19 Remdesivir for 5 or 10 Days in Patients with Severe Covid-19 ./cache/cord-313628-6610z7xk.txt ./txt/cord-313628-6610z7xk.txt